SCHEMBL29601684

SCHEMBL29601684

CCOC(=O)CC(=O)c1ncccc1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.50
MAPT P10636 3/20 0.48
MAPK1 P28482 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
LMNA P02545 2/20 0.46
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ALDH1A1 P00352 3/20 0.44
HTT P42858 3/20 0.44
KDM4E B2RXH2 2/20 0.44
TP53 P04637 1/20 0.44
HPGD P15428 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NLRP3 Q96P20 4/20 0.43
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14263026 1.00 BRD4 (0.50) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL19691717 0.86 BRD4 (0.49) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL2705086 0.85 BRD4 (0.48) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL509093 0.85 BRD4 (0.48) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL14697792 0.85 BRD4 (0.48) BRD4MAPTMAPK1CYP2C19LMNA
SCHEMBL18198238 0.81 BRD4 (0.42) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL29601361 0.81 ALDH1A1 (0.51) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL108857 0.80 BRD4 (0.63) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL5312789 0.80 BRD4 (0.43) BRD4MAPTMAPK1CYP1A2CYP3A4
SCHEMBL14697735 0.79 BRD4 (0.43) BRD4MAPTMAPK1LMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4232449-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES Celgene Corporation (US) 2023-08-30 EP disclosed
CN-116547282-A Heterocyclic compounds and their use for the treatment of helminth infections and diseases 新基公司 2023-08-04 CN disclosed
WO-2022087326-A1 HETEROCYCLIC COMPOUNDS AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES CELGENE CORPORATION (US) 2022-04-28 WO disclosed